ZACKS INVESTMENT MANAGEMENT - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$453,000
-30.1%
109,647
+37.1%
0.01%
-27.8%
Q3 2016$648,000
+0.5%
79,955
-3.3%
0.02%
-10.0%
Q2 2016$645,000
-4.0%
82,659
-5.0%
0.02%
-4.8%
Q1 2016$672,000
-28.4%
87,0420.0%0.02%
-32.3%
Q4 2015$939,000
+161.6%
87,042
+139.0%
0.03%
+181.8%
Q1 2015$359,00036,4180.01%
Other shareholders

There were no reported owners of ACHILLION PHARMACEUTICALS IN in Q1 2016.

NameSharesValueWeighting ↓
View complete list of ACHILLION PHARMACEUTICALS IN shareholders